Biomarkers for Alzheimer’s disease (Q58186173)

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

Europe PubMed Central

title

Biomarkers for Alzheimer’s disease (English)

0 references

1 reference

Malcolm Ward

1

0 references

publication date

September 2007

0 references

published in

0 references

volume

7

0 references

page(s)

635-646

0 references

issue

5

0 references

cites work

Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050.

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Effects of human apolipoprotein E isoforms on the amyloid beta-protein concentration and lipid composition in brain low-density membrane domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Mass spectrometry-based quantitative proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Isolation of N-terminal protein sequence tags from cyanogen bromide cleaved proteins as a novel approach to investigate hydrophobic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Tandem Mass Tags: A Novel Quantification Strategy for Comparative Analysis of Complex Protein Mixtures by MS/MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Complement protein isoforms in CSF as possible biomarkers for neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Mining biomarkers in human sera using proteomic tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Neural cell adhesion molecule in human serum. Increased levels in dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Proteome-based plasma biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Proteomics for the identification of specifically oxidized proteins in brain: technology and application to the study of neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Proline-directed and non-proline-directed phosphorylation of PHF-tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Oxysterols and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Lipid peroxidation in aging brain and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Dual voxel proton magnetic resonance spectroscopy in the healthy elderly: subcortical-frontal axonal N-acetylaspartate levels are correlated with fluid cognitive abilities independent of structural brain changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Imaging beta-amyloid burden in aging and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635

Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.5.635